University of Toronto

  1. McCuaig, J.M., Armel, S.R., Care, M., VOlenik, A., Kim, R.H., & Metcalfe, K.A. (2018). Next-generation service delivery: A scoping review of patient outcomes associated with alternative models of genetic counseling and genetic testing for hereditary cancerCancers (Basel), 10(11). pii: E435. doi: 10.3390/cancers10110435.
  2. Hall, E., Finch, A., Jacobson, M., Rosen, B., Metcalfe, K., Sun, P., Narod, S.A., & Kotsopoulos, J. (2018). Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation. Gynecologic Oncology, Nov 7., pii S0090-8258(18)31355-6. doi: 10.1016/j.ygyno.2018.10.040 [epub ahead of print].
  3. Dossa, F., Cusimano, M.C., Sutradhar, R., Metcalfe, K., Little, T., Lerner-Ellis, J., Eisen, A., Meschino, W.S., Baxter, N.N. (2018). Real-world health services utilisation and outcomes after  BRCA1 and BRCA2 testing in Ontario, Canada: The What Comes Next Cohort study protocolBMJ Open, 8(9), e025317. DOI: 10.1136/bmjopen-2018-25317.
  4. McCuaig, J.M., Stockley, T.L., Shaw, P., Fund-Kee-Fung, M., Altman, A.D., Bentley, J., Bernardini, M.Q., Cormier, B., Hirte, H., Kieser, K., MacMillan, A., Meschino, W.S., Panabaker, K., Perrier, R., Provencher, D., Schrader, K.A., Serfas, K., Tomiak, E., Wong, N., Young, S.S., Gotlieb, W.H., Hoskins, P., Kim, R.H., Brca TtoT Community of Practice (including Metcalfe, K.A.) (2018). Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: A Canadian multisociety roadmap. Journal of Medical Genetics, 55(9), 571-77. DOI: 10.1136/jmedgenet-2018-105472.
  5. Mor, P., Brennenstuhl S., Metcalfe, K.A. (2018). Uptake of preimplantation genetic diagnosis in female BRCA1 and BRCA2 mutation carriersJournal of Genetic Counseling, June 1, DOI: 10.1007/s10897-0264-2. [Epub ahead of print]
  6. Galica, J., Brennenstuhl, S., Maheu, C., Townsley, C., Metcalfe, K. (2018). Examining the dimensionality of the Fear of Cancer Recurrence InventoryPsychooncology, July 11, DOI: 10.1002/pon.4839 [Epub ahead of print].
  7. Metcalfe KA, Lubinski J, Gronwald J, … Narod, SA. (2018). The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer. Clinical Genetics, 93(5), 1063-68.
  8. Metcalfe, K., Zhong, T., O’Neill, A., McCready, D., Chan, L., Butler, K., Brennenstuhl, S., & Hofer, SOP. (2018). Development and Testing of a Decision Aid for Women Considering Delayed Breast Reconstruction. Journal of Plastic, Reconstructive and Aesthetic Surgery, 71(3), 318-26.
  9. Ko, K.P., Kim, S.J., Huzarski, T.,…Kotsopoulos J; Hereditary Breast Cancer Clinical Study Group (including Metcalfe K). (2018). The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer, 142(11), 2263-2272.
  10. Metcalfe, K., Akbari, M.R., Narod, S.A. (2018). Genetic testing for young women with breast cancer. Lancet Oncol, 19(4), e182.
  11. McInerney, N.M., Narod, S., Metcalfe, K., Semple, J., Brown, M.H. (2017). Breast Cancer Genetics for Plastic Surgeons. Plastic and Reconstructive Surgery, 140(3), 455-460.
  12. Liede, A., Mansfield, C.A., Metcalfe, K.A., Price, M.A., kConFab Consortium, Snyder, C., Friedman, S., Amelio, J., Posner, J., Narod, S.A., Lindeman, G.J., Evans, D.G. (2017). Preferences for breast cancer risk reduction among BRCA1/2 mutation carriers: A Discrete Choice Experiment. Breast Cancer Research and Treatment, 165(2), 433-44.
  13. Semple, J., Metcalfe, K., Shoukat, F., Sun, P., & Narod, S. (2017). Survival Differences in Women with and without Autologous Breast Reconstruction after Mastectomy for Breast Cancer. Plastic and Reconstructive Surgery, Global Open, 5(4), e1281
  14. Metcalfe, K., Semple, J., Quan, M.L., Holloway, C., Wright, F., Narod, S., Hofer, S., Bagher, S., Zhong, T. (2017). Why Some Mastectomy Patients Opt to Undergo Delayed Breast Reconstruction: Results of a Long-term Prospective Study. Plastic and Reconstructive Surgery, 139(2), 267-75.
  15. Metcalfe, K., Dennis, C.L., Poll, A., Armel, S., Demsky, R., Carlsson*, L., Nanda, S., Kiss, A., & Narod, S. (2017). Effect of Decision Aid for Breast Cancer Prevention on Decisional Conflict in Women with a BRCA1 or BRCA2 Mutation:  Multisite Randomized Controlled Trial. Genetics in Medicine, 19(3), 330-36.
  16. Kotsopoulos J, Huzarski T, Gronwald J, Singer CF, Moller P, Lynch HT, Armel S, Karlan B, Foulkes WD, Neuhausen SL, Senter L, Tung N, Weitzel JN, Eisen A, Metcalfe K, Eng C, Pal T, Evans G, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group (2016). Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Journal of the National Cancer Institute, 109(1).
  17. Zhong, T., Hu, J., Bagher, S., Vo, A., O’Neill, A.C., Butler,K., Novak, C.B., Hofer, S.O., & Metcalfe, K. (2016). A Comparison of Psychological Response, Body Image, Sexuality, and Quality of Life between Immediate and Delayed Autologous Tissue Breast Reconstruction: A Prospective Long-term Outcome Study. Plastic and Reconstructive Surgery, 138(4), 772-80.
  18. Moran O, Nikitina D, Royer R, Poll A, Metcalfe K, Narod SA, Akbari MR, Kotsopoulos J. (2017). Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel. Breast Cancer Research and Treatment, 161(1), 135-142.
  19. Iqbal J, Nussenzweig A, Lubinski J, Byrski T, Eisen A, Bordeleau L, Tung NM, Manoukian S, Phelan CM, Sun P, Narod SA; Hereditary Breast Cancer Research Group (including Metcalfe, K). (2016). The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study. British Journal of Cancer, 114(10), 1160-4.
  20. Mayo S, Messner HA, Rourke SB, Howell D, Victor JC, Kuruvilla J, Lipton JH, Gupta V, Kim DD, Piescic C, Breen D, Lambie A, Loach D, Michelis FV, Alam N, Uhm J, McGillis L, & Metcalfe K. (2016). Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation. Bone Marrow Transplant, 51(6), 841-7.
  21. Vigod, S., Hussain-Shamsy, N., Grigoriadis, S., Howard, L.M., Metcalfe, K., Oberlander, T.F., Schram, C., Stewart, D.E., & Dennis, C.L. (2016). A patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial. Trials, 17(1), 110.
  22. Finch, A., Wang, M., Fine, A., Atri, L., Khalouei, S., Pupavac, M., Rosen, B., Eisen, A., Elser, C., Charames, G., Metcalfe, K., Chang, M., Narod, S., & Lerner-Ellis, J. (2016).  Genetic testing for BRCA1 and BRCA2 in the Province of Ontario. Clinical Genetics, 89(3), 304-11.
  23. Gronwald J, Glass K, Rosen B, Karlan B, Tung N, Neuhausen SL, Moller P, Ainsworth P, Sun P, Narod SA, Lubinski J, Kotsopoulos J; Hereditary Breast Cancer Clinical Study Group (including Metcalfe, K). (2016) Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Fertility and Sterility, 105 (3), 781-785
  24. Kotsopoulos, J., Lubinski, J., Gronwald, J., et al., and the Hereditary Breast Cancer Clinical Study Group (including Metcalfe, K.). Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer, 137(5), 1136-46.
  25. Metcalfe, K., Eisen, A., Lerner-Ellis, J., & Narod, S.  (2015). Is it Time to Offer BRCA1 and BRCA2 Testing to All Jewish Women?  Current Oncology, 22(4), e233-6.
  26. Semple, J., Metcalfe, K., Lubinski, J., Huzarski, T., Gronwald, J., Armel, S., Lynch, H.T., Karlan, B., Foulkes, W., Singer, C.F., Neuhausen, S.L., Eng, C., Iqbal, J., & Narod, S.A. and the Hereditary Breast Cancer Clinical Study Group (2015). Does the Age of Breast Cancer Diagnosis in First-Degree Relatives Impact on The Risk of Breast Cancer in BRCA1 and BRCA2 Carriers? Breast Cancer Research and Treatment, 154(1), 163-9.
  27. McGillion, M., Victor, C., Carroll, S., Metcalfe, K., O’Keefe-McCarthy, S., Jamal, N., Arthur, H., McKelvie, R., Jolicoeur, M., Hanlon, J., Stone, J., Niznick, J., Beanlands, R., Svorkdal, N., Coyte, P., Stevens, B., Stacey, D. (2015).  The CREATE method for expressing continuous outcome data in absolute terms for use in patient treatment decision aids: A validation studyMedical Decision Making, 35(8), 959-66.
  28. Metcalfe, K., Cil, T., Semple, J., Xuan Li, L., Bagher, S., Zhong, T., Virani, S., Narod, S., Pal, T. (2015). Long-Term Psychosocial Functioning in Women with Bilateral Prophylactic Mastectomy: Does Preservation of the Nipple-Areolar Complex Make a Difference? Annals of Surgical Oncology, 22(10), 3324-30.
  29. Metcalfe, K., Lynch, H.T., Foulkes, W.D., Tung, N., Kim-Sing, C., Olopade, O.I., Eisen, A., Rosen, B., Snyder, C., Gershman, S., Sun, P., & Narod, S.A.. (2015). Effect of Oophorectomy on Survival after Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. JAMA Oncology, 1 (3), 306-13.
  30. Snyder, C., Metcalfe, K., Sopik, V., Royer, R., Zhang, S., Narod, S., Akbari, M., Lynch, H. (2015). Prevalence of PALB2 Mutations in the Creighton University Breast Cancer Family Registry. Breast Cancer Research and Treatment, 150(3), 637-41.
  31. Visscher, K. Metcalfe, K. & Semple, J. (2015). Breast Deformity and Reconstruction in Turner Syndrome: A Collection of Case Studies. Journal of Plastic, Reconstructive and Aesthetic Surgery Open, 4, 16-21.
  32. Semple, J., Sharpe, S., Murnahagn, M.L., Theodoropoulos, J., & Metcalfe, K. (2015). Using a mobile app for monitoring post-operative quality of recovery of patients at home: a feasibility study. Journal of Medical Internet Research mHealth uHealth, 3(1), e18.
  33. Causarano, N. Platt, J., Baxter, N., Bagher, S., Jones, J., Metcalfe, K., Hofer, S., O’Neill, A., Cheng, T., Starenkyj, W., & Zhong, T. (2015). Pre-consultation Educational Group Intervention to Improve Shared Decision-Making for Postmastectomy Breast Reconstruction: A Pilot Randomized Controlled Trial, Supportive Care in Cancer, 23(5), 1365-75.
  34. Metcalfe, K., Zhong, T., Narod, S., Quan, ML., Holloway, C., Hofer, S., Bagher, S., & Semple, J. (2014).  A Prospective Study of Mastectomy Patients With and Without Delayed Breast Reconstruction: Long-Term Psychosocial Functioning in the Breast Cancer Survivorship Period. Journal of Surgical Oncology, 111(3), 258-64.
  35. Gronwald J, Robidoux A, Kim-Sing C, Tung N, Lynch HT, Foulkes WD, Manoukian S, Ainsworth P, Neuhausen SL, Demsky R, Eisen A, Singer CF, Saal H, Senter L, Eng C, Weitzel J, Moller P, Gilchrist DM, Olopade O, Ginsburg O, Sun P, Huzarski T, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group (including Metcalfe, K.). (2014). Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment, 146(2), 421-7.
  36. Fan*, L., Sidani, S., Cooper-Brathwaite, A., & Metcalfe, K.(2014). Effects of a foot self-care educational intervention on improving footwear choices in those with type 2 diabetes at low risk of foot ulceration. Diabetic Foot Canada 2 (2), 4-12.
  37. McGillion MH, Carroll SL, Metcalfe K, Arthur HM, Victor JC, McKelvie R, Jolicoeur EM, Lessard MG, Stone J, Hanlon JG, Svorkdal N, Andrade A, Niznick J, Malysh L, McDonald W, Stevens, B, Coyte P, Stacey D. (2014). Development of a patient decision aid for people with refractory angina: protocol for a three-phase pilot study. Health and Quality of Life Outcomes, 12, 93.
  38. Kotsopoulos, J. Metcalfe, K., Alston, J., Nikitina, D., Ginsburg, O., Eisen, A., Demsky, R., Akbari, M., Zbuk, K., & Narod, S. (2014).  Prospective Study of High-Risk, BRCA1/2-Mutation Negative Women: the ‘Negative Study’BMC Cancer, 14, 221
  39. Zhong T, Novak CB, Bagher S, Maass SW, Zhang J, Arad U, O’Neill AC, Metcalfe KA, Hofer SO.(2014). Using Propensity Score Analysis to Compare Major Complications between DIEP and Free Muscle-Sparing TRAM Flap Breast Reconstructions.  Plastic and Reconstructive Surgery, 133(4), 774-82.
  40. Kotsopoulos J, Lubinski J, Moller P, Lynch HT, Singer CF, Eng C, Neuhausen SL, Karlan B, Kim-Sing C, Huzarski T, Gronwald J, McCuaig J, Senter L, Tung N, Ghadirian P, Eisen A, Gilchrist D, Blum JL, Zakalik D, Pal T, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group (including Metcalfe, K.). (2014). Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Research and Treatment, 143(3), 579-86
  41. Baltzer, H. L., Alonzo, O., Mainprize, J.G. Yaffe, M., Metcalfe, K., Narod, S., Warner, E., & Semple, J.L. (2014) MRI Volumetric Analysis of Breast Fibroglandular Tissue to Assess Risk of the Spared Nipple in BRCA1 and BRCA2 Mutation Carriers. Annals of Surgical Oncology, 21(5), 1583-8.
  42. Finch, A., Lubinski, J., Moller, P., Maehle, L., Singer, C., Senter, L., Rosen, B., Karlan, B., Ghadirian, P., Cybulski, C., Eisen, A., Foulkes, W., Kim-Sing, C., Ainsworth, P., Tung, N., Lynch, H., Neuhausen, S., Metcalfe, K., Thompson, I., Murphy, J., Sun, P., Narod, S. and the Hereditary Ovarian Cancer Clinical Study Group.  (2014). The Impact of Oophorectomy on Cancer Incidence and Mortality in Women who carry a BRCA1 or BRCA2 MutationJournal of Clinical Oncology, 32(15), 1547-53.
  43. Metcalfe, K., Gershman, S., Ghadirian, P., Foulkes, WD., Lynch, H., Tung, N.,  Kim-Sing, C., Olopade, O.I., Eisen, A., Rosen, B., Sun, P., & Narod, S.A. (2014). Contralateral Mastectomy and Survival after Breast Cancer in Carriers of BRCA1 and BRCA2 Mutations:  A Retrospective Analysis.  British Medical Journal, 348, g226.
  44. Valentini A, Lubinski J, Byrski T, Ghadirian P, Moller P, Lynch HT, Ainsworth P, Neuhausen SL, Weitzel J, Singer CF, Olopade OI, Saal H, Lyonnet DS, Foulkes WD, Kim-Sing C, Manoukian S, Zakalik D, Armel S, Senter L, Eng C, Grunfeld E, Chiarelli AM, Poll A, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group (including Metcalfe, K. ). (2013). The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation. Breast Cancer Research and Treatment, 142(1), 177-85.
  45. Zhong, T., Bagher, S., Jindal, K., Zhang, D., O’Neill, A., MacAdam, S., Butler, K., Pusic, A., Hofer, S., & Metcalfe, K. (2013). The Influence of Dispositional Optimism on Decision Regret to Undergo Major Breast Reconstructive Surgery. Journal of Surgical Oncology, 108(8), 526-30.
  46. Zhong, T., Hu, J., Bagher, S., Min, S., Beber, B., Hofer, S., & Metcalfe, K. (2013).  Decision Regret Following Breast Reconstruction: The Role of Self-Efficacy and Satisfaction with Information in the Preoperative Period. Plastic and Reconstructive Surgery, 132 (5), 724e-34e.
  47. Metcalfe, K., Quan, ML., Holloway, C., Eisen, A., Enmore, M., & Narod, S. (2013).  Cancer-Related Distress and Breast Cancer Risk Perception in Sisters of Newly Diagnosed Breast Cancer PatientsCancer, 119(9), 1722-8.
  48. Finch, A., Metcalfe, K., Chiang, J, Elit, L., McLaughlin, J., Springate, C., Esplen, MJ., Murphy, J., Rosen, B., & Narod, S. (2013).  The Impact of Prophylactic Salpingo-oophorectomy on Quality of Life and Psychological Distress in Women with a BRCA Mutation. Psycho-Oncology, 22 (1), 212-19
  49. Narod, S. Metcalfe, K., Lynch, H.T., Ghadirian, P., Robidoux, A., Tung, N., Gaughan,E., Kim-Sing, C., Olopade, O.I., Foulkes, W.D., Robson,  M., Offit, K., Jakubowska, A., Byrski, T., Huzarski, T., Sun, P., & Lubinski, J. (2013).  Should all BRCA1 Mutation Carriers with Breast Cancer Receive Chemotherapy?  Breast Cancer Research and Treatment, 138(1), 273-9.
  50. Pal, T., Doty, A., Thompson, Z., Lee, J., Monteiro, A., Phelan, C., Lancaster, J., Metcalfe, K., Sellers, T., Vadaparampil, S., & Narod, S. (2013) Modes of Delivery of Genetic Testing Services and the Uptake of Risk Management Options in BRCA1 and BRCA2 CarriersClinical Genetics, 85(1), 49-53. 
  51. Pal T, Vadaparampil S, Kim J, Xu Y, Friedman S, Narod SA, Metcalfe K. (2013).  Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriersFamilial Cancer, 12(4), 615-9.
  52. Fan, L., Sidani, S., Cooper-Brathwaite, A., & Metcalfe, K. (2013). Feasibility, Acceptability and Effects of a Foot Self-Care Educational Intervention on Minor Foot Problems in Adult Patients with Diabetes at Low Risk for Foot Ulceration: A Pilot StudyCan J Diabetes, 37(3), 195-201.
  53. Semple, J., Metcalfe, K., Lynch, H., Kim-Sing, C., Senter, L., Pal, T., Ainsworth, P., Lubinski, J., Tung, N., Eng,, C., Gilchrist, D., Blum, J., Neuhausen, S., Singer, C., Sun, P., & Narod, S. (2013). International Rates of Breast Reconstruction following Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation CarriersAnnals of Surgical Oncology, 20(12), 381-22.
  54. Metcalfe, K. Poll, A., Royer, R., Nanda, S., Llacuachaqui, M., Sun, P., & Narod, S. (2013). A Comparison of the Yield of BRCA Mutation Carriers Through the Provision of Jewish Population-Based Genetic Testing Compared to Clinical Based Genetic Testing. British Journal of Cancer, 109(3), 7797-9.
  55. Platt, J., Baxter, N., Jones, J., Metcalfe, K., Causarano, N., Hofer, S., O’Neill, A., Cheng, T., Starenkyj, E., & Zhong, T. (2013). Pre-Consultation Educational Group Intervention to Improve Shared Decision-Making in Postmastectomy Breast Reconstruction: A Mixed-Methods Pilot RCT. Trials, 14, 199.
  56. Fan L, Sidani S, Cooper-Brathwaite A, Metcalfe K. (2013). Improving Foot Self-Care Knowledge, Self-Efficacy, and Behaviors in Patients With type 2 Diabetes at Low Risk for Foot Ulceration: A Pilot StudyClin Nurs Res. 2013 Jul 3
  57. Metcalfe, K., Kim-Sing, C., Ghadirian, P., Sun, P., & Narod, S. (2013). Healthcare Providers’ Recommendations for Cancer Prevention in BRCA1 and BRCA2 Mutation CarriersClinical Genetics, 85(1), 25-30.
  58. Bordeleau L, Lipscombe L, Lubinski J, Ghadirian P, Foulkes WD, Neuhausen S, Ainsworth P, Pollak M, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group (including Metcalfe, K.). (2011). Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations. Cancer, 117(9), 1812-8.
  59. Metcalfe, K., Semple, J., Quan, ML., Vadaparampil, S., Holloway, C., Brown, M.,  Bower, B., Sun, P., & Narod, S. (2012).  Changes in Psychosocial Functioning One Year After Mastectomy Alone, Delayed Breast Reconstruction or Immediate Breast ReconstructionAnnals of Surgical Oncology. 19(1), 233-41
  60. Ertmański S, Metcalfe K, Trempała J, Głowacka M, Lubiński J, Narod S, Gronwald J. (2012). Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutationHered Cancer Clin Pract, 10 Suppl 1, A14.
  61. Lam, A., Secord, S., ButlerK, Hofer, S., Liu, E., Metcalfe K, & Zhong, T. (2012). A Breast Reconstruction Needs Assessment: How Does Self-Efficacy Affect Information Access and Preferences? Canadian Journal of Plastic Surgery, 20(1), 37-42.
  62. Kotsopoulos J, Lubinski J, Salmena L, Lynch HT, Kim-Sing C, Foulkes WD, Ghadirian P, Neuhausen SL, Demsky R, Tung N, Ainsworth P, Senter L, Eisen A, Eng C, Singer C, Ginsburg O, Blum J, Huzarski T, Poll A, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group (including Metcalfe, K.). (2012). Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.  Breast Cancer Research and Treatment, 14 (2), R42.
  63. Wong J, D’Alimonte L, Angus J, Paszat L, Metcalfe K, Whelan T, Llewellyn-Thomas H, Warner E, Franssen E, Szumacher E. (2012). Development of Patients’ Decision Aid for Older Women with Stage I Breast Cancer Considering Radiotherapy after Lumpectomy. Int J Radiat Oncol Biol Phys., 84 (1), 30-8.
  64. Metcalfe, K, Lynch, H, Ghadirian, P, Tung, N, Olivotto, I, Foulkes, W, Warner, E, Olopade, O, Eisen, A, Weber, B, McLennan, J, Sun, P, & Narod, S. (2011). Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.  British Journal of Cancer, 104(9), 1384-92.
  65. Metcalfe, K. Mian, N., Enmore, M., Poll, A., Llacuachaqui, M., Nanda, S., Sun, P., Hughes, K., &  Narod, S., (2011).  Long-Term Follow-up of Jewish Women with a BRCA1or BRCA2 Mutation who Underwent Population Genetic Screening.  Breast Cancer Research and Treatment, 133(2), 735-40.
  66. Finch, AP, Metcalfe KA, Chiang JK,  Elit L,  Springate C,  Demsky R, Murphy J, Rosen B and Narod SA . (2011). The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual functioning in women who carry a BRCA mutation.  Gynecologic Oncology 121(1), 163-8l
  67. Metcalfe, K., Poll, A., Nanda, S., Royer, R., Llacuachaqui, M., Tulman, A., Sun, P., and Narod, S. (2010).Satisfaction, breast cancer risk perception, and cancer-related distress in unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.  Clinical Genetics, 78(5), 411-7.
  68. Brown, S., Osann, K., Culver, J., MacDonald, D., Sand, S., Thornton, A., Brown, D. Metcalfe, K., Burke, H., Robson, M., Grant, M., & Weitzel, J. (2010). Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates.  Patient Education and Counselling, 83(1), 92-8.
  69. Metcalfe, K., Lubinski, J., Lynch, H., Ghadirian, P., Foulkes, W., Kim-Sing, C., Neuhausen, S., Tung, N., Rosen, B., Gronwald, J., Ainsworth, P., Sweet, K., Eisen, A., Sun, P., Narod, S. (2010).  Family History of Cancer and the Risk of Cancer in Women with a BRCA1 or BRCA2 Mutation.  Journal of the National Cancer Institute, 102(24), 1874-8.
  70. Metcalfe, K, Lynch, H, Ghadirian, P, Tung, N, Olivotto, I, Foulkes, W, Warner, E, Olopade, O, Eisen, A, Weber, B, McLennan, J, Sun, P, & Narod, S. (2010).  Risk of ipsilateral breast cancer  in women with a BRCA1 or BRCA2 Mutation.  Breast Cancer Research and Treatment, 127(1), 287-96.
  71. Culver, J., MacDonald, J.,  Thornton, A., Sand, S., Grant, M., Bowen, D., Burke, H., Garcia, N., Metcalfe, K, & Weitzel, J. (2010).  Development and Evaluation of a Decision Aid for BRCA carriers with breast cancer.  Journal of Genetic Counseling 20(3), 294-307.
  72. Finch, A., Metcalfe, K. Lui, J., Springate, C., Demsky, R., Rosen, B., Murphy, J., Sun, P., & Narod, S.  (2009).  Breast and Ovarian Cancer Risk Perception Among Women That Have Undergone Prophylactic Salpingo-Oophorectomy Due to Inherited Mutations in the BRCA1 and BRCA2 GenesClinical Genetics 75(3), 220-4.
  73. Metcalfe, K. (2009) Prophylactic Oophorectomy for Breast Cancer Prevention.  Journal of Women’s Health, 5(1), 63-8.
  74. Metcalfe, K. Poll. A., Finch, A., Horsman, D., Kim-Sing, C., Sun, P., Narod, S. (2009).  Cancer Risks in Women with a Family History of Breast and/or Ovarian Cancer who have Tested Negative for a BRCA1 or BRCA2 MutationBritish Journal of Cancer, 100(2), 421-5.
  75. Ertmański, S., Metcalfe, K., Trempała, J., Głowacka, M., Lubiński, J., Narod, S., & Gronwald, J. (2009).  Identification of Patients at High Risk of Psychological Distress after BRCA1 Genetic Testing. Genet Test Mol Biomarkers, 13(3), 325-30.
  76. Buick, C., & Metcalfe, K.  (2009)  Human Papilloma Vaccine:  An oncology nursing issueCanadian Oncology Nursing Journal, 19(2), 60-4
  77. Esplen, MJ, Stuckless, N, Hunter, J, Narod, S, Liede, A, Metcalfe, K, Butler, K, Glendon, G, Irwin, E, Scott, J. (2009) The BRCA Self Concept Scale: A new instrument to measure self-concept in BRCA1/2 mutation carriers. Psycho-Oncology, 18(11), 1216-29.
  78. Metcalfe, K., Poll, A., Royer, R., Llacuachaqui, M., Tulman, A., Sun, P., and Narod, S. (2009).  Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish WomenJournal of Clinical Oncology, 28(3), 387-91.
  79. Metcalfe, K., Birenbaum-Carmeli. D., Lubinski, J., Gronwald, J., Lynch, H., Moller, P., Ghadirian, P., Foulkes, W., Friedman, E., Kim-Sing, C., Ainsworth, P., Rosen, B., Domchek, S., Wagner, T., Tung, N., Manoukian, S., Couch, F., Sun, P., & Narod, S. (2008). International Variation in Rates of Uptake of Preventive Options in BRCA1 and BRCA2 Mutation CarriersInternational Journal of Cancer, 122(9),  2017-2022.
  80. Metcalfe, K. Fan, I., McLaughlin, J., Risch, H., Rosen, B., Murphy, J., Bradley, L., Royer, R., Sun, P., & Narod, S. (2008).  Uptake of Genetic Testing in Ovarian Cancer Patients in Canada:  A Population Based StudyGynecologic Oncology, 112(1), 68-72.
  81. Metcalfe, K., Lubinski, J., Ghadirian, P., Lynch, H., Kim-Sing, C., Friedman, E., Foulkes, Domchek, S., Ainsworth, P., Isaacs, C., Tung, N., Gronwald, J., Cummings, S., Wagner, T., Manoukian, S., Moller, P., Sun, P., & Narod, S. (2008).  Predictors of Contralateral Prophylactic Mastectomy in Women with a BRCA1 or BRCA2 Mutation.  Journal of Clinical Oncology, 26(7), 1093-1097.
  82. Metcalfe, K., Ghadirian, P., Foulkes, W., Kim-Sing, C., Ainsworth, P., Rosen, B., Armel, S., Poll, A., Eisen, A., Gilchrist, D., Chudley, A., Maugard, C., Lemire, E., Sun, P., & Narod, S. (2008) Family History as a Predictor of Uptake of Cancer Preventive Procedures by Women with a BRCA1 or BRCA2 MutationClinical Genetics, 73(5), 474-479.
  83. Metcalfe, K, Ghadirian, P., Rosen, B., Foulkes, W., Kim-Sing, C., Eisen, A., Ainsworth, P., Horsman, D., Maugard, C., Provencher, D., Robidoux, A., Gilchrist, D., Chudley, A., Lemire, E., Sun, P., & Narod, S. (2007). Variation in Rates of Uptake of Preventive Options in BRCA1 and BRCA2 Mutation Carriers Across CanadaOpen Medicine, 1(2), E92-98.
  84. Metcalfe, K, Poll, A., O’Connor, A., Gershman, S., Armel, S., Finch, A., Demsky, R., Rosen, B., & Narod, S. (2007).  Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.  Clinical Genetics, 72, 208-217.
  85. Metcalfe, K. & Narod, S. (2007). The Prevention of Hereditary Breast CancerOpen Medicine, 1(3), 184-190.
  86. Lynch, HT, Snyder, C, Lynch, JF, Karatoprakli, P, Coronel, S, Trowonou, A, Metcalfe, K, Narod, SA ,Gong, G. (2006).  Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.  Cancer Genetics and Cytogenetics, 165 (2), 91-97.
  87. Gronwald,J, B Górski,B, Huzarski, T, Byrski, T, Metcalfe,K, Narod, S, Lubiński, J.  Direct-to-Patient BRCA1 Testing: the Twoj Styl Experience . (2006) Breast Cancer Research and Treatment, 100(3), 239-45.
  88. Metcalfe, K, Lynch, H, Ghadirian, P, Tung, N, Olivotto, I, Foulkes, W, Warner, E, Olopade, O, Eisen, A, Weber, B, McLennan, J, Sun, P, & Narod, S. (2005).  The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 CarriersGynecologic Oncology, 96(2005), 222-226.
  89. Metcalfe, K., Esplen, M.J., Goel, V., & Narod, S.  (2005).  Predictors of quality of life in women with bilateral prophylactic mastectomy.  The Breast Journal, 11(1), 65-69.
  90. Metcalfe, K, Seidel, J, Hanna, D, Snyder, C, Lynch, H, & Narod, S. (2005).  The use of preventive measures among health women who carry a BRCA1 or BRCA2 mutation.  Familial Cancer, 4(2) 97-103.
  91. Metcalfe, K, Semple, J. & Narod, S.  (2005).  Time to reconsider subcutaneous mastectomy for breast cancer prevention?   The Lancet Oncology6(6), 431-434.
  92. Weitzel JN, Robson M, Pasini B, Manoukian S, Stoppa-Lyonnet D, Lynch HT, McLennan J, Foulkes WD, Wagner T, Tung N, Ghadirian P, Olopade O, Isaacs C, Kim-Sing C, Moller P, Neuhausen SL, Metcalfe K, Sun P, Narod SA. (2005).  A comparison of bilateral breast cancers in BRCA carriersCancer Epidemiology, Biomarkers and Prevention, 14(6), 1534-8.
  93. Metcalfe, K, Foulkes, W, Lynch, H, Ghadirian, P, Tung, N, Olivotto, I, Warner, E, Olopade, O, Eisen, A, Weber, B, McLennan, J, Sun, P, & Narod, S. (2005). The Effect of Prior Bilateral Salpingo-Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation CarriersHereditary Factors in Clinical Cancer, 3(2), 53-57.
  94. Metcalfe, K., Esplen, M.J., Goel, V., & Narod, S.  (2004).  Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.  Psycho-Oncology, 13(1), 14-25.
  95. Menkiszak, J., Rzepka-Gorska, I., Gorski, B., Gronwald, J., Huzarski, T., Byrski. T., Jakubowska, A., Metcalfe, K., Narod, S., & Lubinski, J.  (2004).  Attitudes toward preventive oophorectomy among BRCA1 carriers in Poland.  European Journal of Gynecological Oncology, 25(1), 93-95.
  96. Foulkes, WD, Metcalfe, K, Sun, P., Hanna, W, Lynch HT, Ghadirian, P, Tung, N, Olopade, O, Weber, B, McLennan, J, Olivotto, O, Begin, LR, & Narod, SA.  (2004).  Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type.  Clinical Cancer Research, 10(6), 2029-2034.
  97. Metcalfe, K, Lynch, H, Ghadirian, P, Tung, N, Olivotto, I, Foulkes, W, Warner, E, Olopade, O, Eisen, A, Weber, B, McLennan, J, Sun, P, & Narod, S. (2004).  Contralateral breast cancer in BRCA1 and BRCA2 mutation carriersJournal of Clinical Oncology, 22(12), 2328-35.
  98. Metcalfe, K., Semple, J., & Narod, S.  (2004).  Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: A descriptive studyPlastic and Reconstructive Surgery, 114(2), 360-366.
  99. Metcalfe, K. (2004).  Prophylactic bilateral mastectomy for breast cancer prevention.  Journal of Women’s Health, 13(7), pp. 822-829.
  100. Esplen, M.J.,  Hunter, J.,  Leszcz, M., Warner, E., Narod, S., Metcalfe, K., Butler, K.,  Liede, A., Young, M.A., Kieffer, S., DiProspero, L. & Irwin, E. (2004).  A multicenter study of supportive-expressive group therapy for women with BRCA1/2 mutations.  Cancer, 101(10), pp. 2327-2340.
  101. Foulkes, WD, Metcalfe, K, Hanna, W, Lynch HT, Ghadirian, P, Tung, N, Olopade, O, Weber, B, McLennan, J, Olivotto, O, Sun, P, Chappuis, PO, Begin, LR, Brunet, JS,  Narod, SA.  (2003). Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinomaCancer, 98(8), 1569-1577.
  102. Metcalfe, K., Goel, V., Lickley, L., Semple, J., & Narod, S.  (2002). Prophylactic bilateral mastectomy: Patterns of practice.  Cancer, 95(2), 236-242.
  103. Metcalfe, K. & Narod, S.  (2002).  Breast cancer risk in women with prophylactic mastectomy: A comparison of patients’ subjective and model-generated risk estimates.  Journal of the National Cancer Institute, 94 (20), 1564-1569.
  104. Metcalfe, K.., Liede, A., Trinkaus, M., Hanna, D., & Narod, S.  (2002).  Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2.  Clinical Genetics, 62(6), 464-469.
  105. Elit, L., Metcalfe, K., Goel, V., & Narod, S.  (2001).  Patterns of hospital administrative and ethical review processes.  Annals of the Royal College of Physicians and Surgeons of Canada , 34(4),  206-209.
  106. Liede, A., Metcalfe, K., Hanna, D., Hoodfar, E., Snyder, C., Durham, C., Lynch, H., & Narod, S.  (2000).    Evaluation of the Needs of Male Carriers of Mutations in BRCA1 or BRCA2 Who Have Undergone Genetic Counselling.  American Journal of Human Genetics, 67 (6), 1494-1504.
  107. Metcalfe, K., Liede, A., Hoodfar, E., Foulkes, W., & Narod, S. (2000).  An evaluation of needs among female BRCA1 and BRCA2 carriers undergoing genetic counseling.  Journal of Medical Genetics, 37 (11), 866-874.
  108. Metcalfe, K., Langstaff, J., Evans, S., Paterson, H., & Reid, J.  (1998).  Meeting the needs of women living with HIVPublic Health Nursing, 15 (1), 30-34.
  109. Liede, A., Metcalfe, K., Offit, K., Brown, K., Miller, S., Narod, S., & Moslehi.  (1998).  A family with three germline mutations in BRCA1 and BRCA2. Clinical Genetics, 54(3), 215-8.